SOMERSET, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its first quarter 2025 unaudited ...

Legend Biotech Corporation Sponsored ADR (LEGN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the ...

Legend Biotech had a negative net margin of 66.92% and a negative return on equity of 29.69%. The firm’s quarterly revenue was up 134.6% compared to the same quarter last year.

Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Equities research analysts at HC Wainwright raised their Q4 2024 earnings estimates for shares of Legend Biotech in a report issued on Thursday ...

SOMERSET, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that ...

Legend Biotech is headquartered in Somerset, NJ. The stock currently trades for around $42.00 a share and sports an approximate $7.8 billion market capitalization. Carvykti received approval to ...

Tuesday, Redburn-Atlantic initiated coverage on Legend Biotech Corp. (NASDAQ: LEGN) stock, a commercial-stage biotechnology company, with a Buy rating and an $86.00 price target. The firm's ...

Frank Zhang, a globally recognized scholar in the field of capital markets, has been appointed the James L. Frank ’32 Professor of Accounting, effective immediately. He is a member of the faculty at ...

SOMERSET, N.J., July 26, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced preliminary, unaudited financial results ...